How to Value a Veterinary Specialty Practice

Veterinary specialty practices are not general practices, and they're not emergency hospitals. I make that distinction upfront because too many owners — and too many brokers — try to value a specialty referral practice using the same framework they'd apply to a four-doctor general practice. The economics are fundamentally different, and so is the buyer landscape.

I've advised on specialty vet transactions ranging from single-surgeon orthopedic practices to multi-specialty referral centers with oncology, cardiology, and internal medicine under one roof. The valuation principles that drive these deals are distinct enough to warrant their own framework.

What Makes Specialty Different

A general veterinary practice generates $200-$400 per visit on wellness exams, vaccinations, and routine procedures. A specialty practice generates $1,500-$5,000+ per case on complex surgeries, cancer treatment protocols, advanced diagnostics, and specialty consultations. The revenue per case is 5-15x higher, which changes everything about the financial model.

But that higher revenue comes with higher costs. Board-certified veterinary specialists command $250K-$450K in total compensation — two to three times what a general practitioner earns. Equipment costs are substantial: an MRI machine for neurology runs $1.5-$3M, a linear accelerator for radiation oncology costs $2-$5M, and even basic surgical suites for orthopedics require $300K-$500K in specialized instruments.

The result is a practice with high revenue, high costs, and EBITDA margins that can range from 12% (poorly managed, equipment-heavy) to 30%+ (efficient multi-specialty with shared infrastructure). Where your margin falls within that range drives your valuation more than any other factor.

Valuation Multiples by Practice Type

Specialty veterinary practices typically trade at 7-14x EBITDA, meaningfully above the 5-9x range for general veterinary practices. The premium reflects higher barriers to entry, deeper competitive moats, and the extreme difficulty of recruiting specialists.

Veterinary surgery (orthopedic, soft tissue): 7-11x EBITDA. The most common specialty and the most accessible for acquirers. Surgeon recruitment is difficult but not impossible. Equipment costs are moderate compared to other specialties.

Veterinary oncology: 8-13x EBITDA. Oncology practices with radiation therapy capabilities command the highest multiples because the equipment barrier ($2-$5M for a linear accelerator) creates a natural moat. There are fewer than 400 board-certified veterinary oncologists in the US, making recruitment extremely competitive.

Veterinary cardiology: 8-12x EBITDA. Cardiology is growing rapidly as pet owners increasingly pursue interventional procedures (pacemakers, balloon valvuloplasty). The specialty requires expensive imaging equipment but generates excellent revenue per case.

Veterinary neurology: 9-14x EBITDA. Neurology practices with in-house MRI are among the highest-valued veterinary assets. There are roughly 350 board-certified veterinary neurologists in the US, and the MRI equipment creates a capital barrier that protects margins.

Multi-specialty referral centers:10-14x EBITDA. A center offering 3+ specialties under one roof with shared imaging, anesthesia, and support staff is the most valuable configuration. The cross-referral efficiency and shared overhead create margin advantages that single-specialty practices can't match.

The Referral Network Is Everything

Unlike general practices where clients walk in off the street, specialty practices depend almost entirely on referrals from general practitioners. The strength and breadth of your referral network is arguably the most important intangible asset you have.

I look at three things when evaluating referral networks. First, the number of referring practices — a healthy specialty practice should have 50-200+ active referring veterinarians. Second, concentration — if your top 5 referring practices account for 40%+ of your caseload, you have a referral concentration risk that buyers will discount. Third, the geographic radius — specialty practices with referral networks spanning 60-90+ miles have a much larger addressable market than those drawing from a 20-mile radius.

Buyers will examine your referral patterns during due diligence with forensic intensity. They want to know whether referring vets send cases to your practice or to your specific specialist. If Dr. Martinez's oncology caseload follows Dr. Martinez rather than the practice, that's a significant risk factor.

Specialist Recruitment: The Constraint That Drives Value

The single biggest constraint in veterinary specialty M&A is talent. There are approximately 14,000 board-certified veterinary specialists in the US across all disciplines, compared to over 120,000 general practitioners. Residency programs produce maybe 600-800 new specialists per year, and demand far outstrips supply.

This talent scarcity directly impacts valuation in two ways. First, it creates a barrier to entry that protects existing practices — you can't open a competing neurology practice if there are no neurologists to hire. Second, it means acquirers are often buying access to specialists they couldn't recruit independently.

The flip side is that specialist retention risk is the biggest post-acquisition concern. If your lead surgeon or oncologist leaves after the acquisition, 30-50% of that specialty's revenue could walk out the door. Buyers mitigate this through employment agreements, non-competes, retention bonuses, and equity participation — but they also price the risk into their offer.

The Acquirer Landscape

The veterinary specialty acquisition market is dominated by a handful of well-capitalized platforms that understand the nuances of referral medicine. NVA (National Veterinary Associates), Ethos Veterinary Health, and BluePearl (owned by Mars) are the most active buyers of specialty practices. Each has a slightly different model.

NVA and Ethos tend to acquire standalone specialty practices and integrate them into regional referral networks. BluePearl typically acquires practices that can operate under the BluePearl brand as combined specialty and emergency hospital facilities. The Mars backing gives BluePearl essentially unlimited capital, but their brand integration requirements aren't for everyone.

Private equity interest in veterinary specialty has surged. Firms like KKR (via PetVet), Ares Management, and Shore Capital Partners are all active. These PE buyers look for practices with $2M+ EBITDA, multiple specialists, and growth potential through adding specialties or expanding geographic reach.

What Drives Premium Multiples

Emergency affiliation.A specialty practice co-located with or affiliated with an emergency service is substantially more valuable than a standalone daytime-only specialty practice. Emergency cases that convert to specialty follow-up represent a built-in referral pipeline that doesn't depend on external referring veterinarians.

Equipment condition and vintage. A practice with a 3-year-old MRI is worth more than one with a 12-year-old MRI that needs $2M in replacement. Buyers will assess equipment condition and factor near-term capital expenditure requirements into their pricing. Having current equipment on reasonable lease terms is ideal.

Specialist depth. Having two or three specialists in the same discipline provides coverage, reduces key-person risk, and signals a practice large enough to sustain caseload fluctuations. Single-specialist practices are inherently riskier.

Case volume growth. Specialty case volume growing at 5%+ annually demonstrates both market demand and referral network strength. Flat or declining case volume, especially in a growing market, signals competitive or reputation issues.

The Bottom Line

Veterinary specialty practices sit at the premium end of the veterinary M&A market, and for good reason. The combination of high revenue per case, specialist scarcity, equipment barriers to entry, and active corporate acquirers creates a favorable environment for sellers. But the same factors that drive high multiples — specialist dependency, referral concentration, equipment intensity — are also the biggest risks buyers scrutinize. The practices that command top-of-market multiples are those that have built systems and teams that outlast any single specialist.